Transforming Growth Factor‐β in Psoriasis: Pathogenesis and Therapy

This publication has 33 references indexed in Scilit:

• Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-α production in keratinocytes cultured from psoriatic lesions
  British Journal of Dermatology, 1989
• Transforming growth factor‐β1 is a potent inducer of plasminogen activator inhibitor type‐1 in human glioblastoma and carcinoma cell lines
  APMIS, 1988
• Transforming growth factor-βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation
  Cellular Immunology, 1988
• Human Keratinocytes Catabolize Thymidine
  Journal of Investigative Dermatology, 1988
• Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β
  Science, 1987
• The TGF-β family of growth and differentiation factors
  Cell, 1987
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
  The Journal of Experimental Medicine, 1986
• Subpopulations of Mononuclear Cells in Microscopic Lesions of Psoriatic Patients. Selective Accumulation of Suppressor/Cytotoxic T Cells in Epidermis During the Evolution of the Lesion
  Journal of Investigative Dermatology, 1984
• Psoriasis
  Journal of the American Academy of Dermatology, 1984
• Autoradiographic Analysis of Turnover Times of Normal and Psoriatic Epidermis**From the Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Public Health Service, U.S. Department of Health, Education and Welfare.
  Journal of Investigative Dermatology, 1965